BioSensics
BioSensics, based in Cambridge, US, is a global provider of wearable sensor tech for medical use and research.
Founded
2007BioSensics, based in Cambridge, US, is a global provider of wearable sensor tech for medical use and research.
biosensics.comCrawled Oct 15, 2026
The first FDA-listed wearable-based medical device for objective assessment of balance.
eCOA, digital speech and cognitive assessments, video capture and precision motion measurements, all collected using a single integrated solution.
A comprehensive database of disease-specific digital biomarkers.
A comprehensive, patient-centric solution for the remote collection of high-quality digital data from study participants.
BioSensics planned to sponsor and attend the 2022 International Congress of Parkinson's Disease and Movement Disorders in Madrid. Its products for measuring digital biomarkers in neurological and neuromuscular disorders include LEGSys and BalanSe.
BioSensics planned to sponsor, attend, and present at the 2023 AAN Annual Meeting in Boston, with five oral and poster presentations on digital measurement tools and biomarkers for various conditions.
BioSensics planned to sponsor, exhibit, and present at the IEEE-EMBS International Conference on Body Sensor Networks at the MIT Media Lab in Cambridge. Its five poster presentations covered digital measurement tools and sensor-based biomarkers.
BioSensics planned to sponsor and attend the 2023 MDA Clinical & Scientific Conference in Dallas. A BioSensics representative was scheduled to speak in the “Remote Outcomes and Decentralized Studies” session.
BioSensics was founded in 2007 by three scientists from Harvard University. It develops wearable sensor technologies for healthcare and medical alerts, used by thousands of older adults.
BioSensics, LLC's privacy notice describes how it collects and uses personally identifiable information, which it calls Personal Data.